Albemarle (NYSE:ALB) Sets New 12-Month Low – What’s Next?

Albemarle Co. (NYSE:ALBGet Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $66.15 and last traded at $67.42, with a volume of 856554 shares trading hands. The stock had previously closed at $72.25.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Piper Sandler lowered their price objective on shares of Albemarle from $90.00 to $85.00 and set an “underweight” rating for the company in a research report on Thursday, February 20th. Royal Bank of Canada lowered their price target on Albemarle from $133.00 to $114.00 and set an “overweight” rating for the company in a report on Wednesday, February 12th. Scotiabank dropped their price objective on Albemarle from $85.00 to $75.00 and set a “sector perform” rating on the stock in a research note on Tuesday, February 18th. Clarkson Capital began coverage on Albemarle in a research report on Tuesday, January 14th. They set a “buy” rating and a $112.00 target price for the company. Finally, Robert W. Baird cut their price target on Albemarle from $103.00 to $92.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $104.30.

Get Our Latest Report on Albemarle

Albemarle Stock Down 7.9 %

The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $7.82 billion, a price-to-earnings ratio of -5.96 and a beta of 1.70. The company has a 50-day moving average of $78.53 and a 200-day moving average of $90.52.

Albemarle (NYSE:ALBGet Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.49). Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%. On average, equities analysts predict that Albemarle Co. will post -0.04 earnings per share for the current fiscal year.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Friday, March 14th were issued a $0.405 dividend. The ex-dividend date was Friday, March 14th. This represents a $1.62 annualized dividend and a dividend yield of 2.43%. Albemarle’s dividend payout ratio (DPR) is presently -14.46%.

Hedge Funds Weigh In On Albemarle

Several institutional investors have recently made changes to their positions in ALB. Quarry LP raised its stake in shares of Albemarle by 1,400.0% during the 3rd quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 252 shares during the period. Assetmark Inc. grew its stake in Albemarle by 340.6% during the 4th quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 235 shares in the last quarter. Trust Co. of Vermont increased its stake in shares of Albemarle by 606.5% in the 4th quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 279 shares during the last quarter. First Community Trust NA boosted its holdings in Albemarle by 55.0% in the 4th quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after purchasing an additional 142 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Albemarle during the 4th quarter valued at approximately $34,000. 92.87% of the stock is owned by hedge funds and other institutional investors.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Stories

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.